Sanofi adopts TriNetX platform to speed clinical trials
TriNetX has announced that it will be assisting Sanofi by using patient EHRs to optimize recruitment, streamline trial investigators’ workflows…
BioProtect Launches an International Multi-Center Clinical Study Following FDA investigational Device Exemption (IDE)
FDA has granted investigational Device Exemption approval (IDE) to conduct a pivotal clinical study examining theuse of the ProSpace[TM] Balloon…
FDA lifts clinical hold on fitusiran
Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…